These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11859)

  • 21. Fanconi's anemia treated by allogeneic marrow transplantation.
    Deeg HJ; Storb R; Thomas ED; Appelbaum F; Buckner CD; Clift RA; Doney K; Johnson L; Sanders JE; Stewart P; Sullivan KM; Witherspoon RP
    Blood; 1983 May; 61(5):954-9. PubMed ID: 6338978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful allogeneic bone marrow retransplantation with the same donor after graft rejection: application of a modified conditioning regimen.
    Gmür J; Frick PG; von Felten A
    Blut; 1979 Jul; 39(1):47-52. PubMed ID: 380689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
    Champlin RE; Perez WS; Passweg JR; Klein JP; Camitta BM; Gluckman E; Bredeson CN; Eapen M; Horowitz MM
    Blood; 2007 May; 109(10):4582-5. PubMed ID: 17272503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
    Hill RS; Petersen FB; Storb R; Appelbaum FR; Doney K; Dahlberg S; Ramberg R; Thomas ED
    Blood; 1986 Mar; 67(3):811-6. PubMed ID: 3511988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
    Horstmann M; Stockschläder M; Krüger W; Hoffknecht M; Betker R; Kabisch H; Zander A
    Ann Hematol; 1995 Aug; 71(2):77-81. PubMed ID: 7654856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with second marrow transplants.
    Wright SE; Thomas ED; Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R
    Exp Hematol; 1976 Jul; 4(4):221-6. PubMed ID: 782896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
    Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
    Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.
    Bayever E; Champlin R; Ho W; Lenarsky C; Storch S; Ladisch S; Gale RP; Feig SA
    J Pediatr; 1984 Dec; 105(6):920-5. PubMed ID: 6389812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor.
    Bunin N; Leahey A; Kamani N; August C
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marrow transplantation in hepatitis-associated aplastic anemia.
    Witherspoon RP; Storb R; Shulman H; Buckner CD; Deeg HJ; Clift RA; Sanders JE; Doney K; McDonald G; Sullivan KM
    Am J Hematol; 1984 Oct; 17(3):269-78. PubMed ID: 6383025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation for severe aplastic anemia in Japan.
    Kanamaru A; Nagai K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.
    Storb R; Doney KC; Thomas ED; Appelbaum F; Buckner CD; Clift RA; Deeg HJ; Goodell BW; Hackman R; Hansen JA; Sanders J; Sullivan K; Weiden PL; Witherspoon RP
    Blood; 1982 Feb; 59(2):236-46. PubMed ID: 7034811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful retransplantation of bone marrow following failure of initial engraftment in a patient with aplastic anemia.
    Meuwissen HJ; Moore EC; Strauss HS; Taft E; Britten A
    J Pediatr; 1976 Oct; 89(4):588-92. PubMed ID: 784930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.